A discussion unfolds about the contrasting accountability of public and private institutions. While the FDA often receives increased funding after failures, private companies thrive on competition, leading to better outcomes. The conversation also explores how private schools, despite similar funding to public schools, achieve superior results, primarily due to their flexibility in curriculum and management.
